|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:acquiredBy
|
gptkb:Nestlé
gptkb:Novartis
|
|
gptkbp:CEO
|
gptkb:David_J._Endicott
|
|
gptkbp:divested
|
gptkb:Novartis
|
|
gptkbp:founded
|
1945
|
|
gptkbp:founder
|
gptkb:William_Conner
gptkb:Robert_Alexander
|
|
gptkbp:headquartersLocation
|
gptkb:Geneva,_Switzerland
gptkb:Fort_Worth,_Texas,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Alcon Laboratories
|
|
gptkbp:independenceDate
|
2019
|
|
gptkbp:industry
|
ophthalmology
|
|
gptkbp:logo
|
Alcon logo.svg
|
|
gptkbp:netIncome
|
$0.7 billion (2022)
|
|
gptkbp:notableProduct
|
gptkb:AIR_OPTIX_contact_lenses
gptkb:AcrySof_intraocular_lens
gptkb:DAILIES_contact_lenses
gptkb:Systane_eye_drops
|
|
gptkbp:numberOfEmployees
|
over 24,000
|
|
gptkbp:officeLocation
|
gptkb:Geneva,_Switzerland
gptkb:Fort_Worth,_Texas,_United_States
|
|
gptkbp:parentCompany
|
gptkb:Novartis
|
|
gptkbp:products
|
pharmaceuticals
contact lenses
eye care products
surgical equipment
|
|
gptkbp:publiclyTraded
|
gptkb:NYSE:ALC
gptkb:SIX:ALC
|
|
gptkbp:revenue
|
$8.7 billion (2022)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:specializesIn
|
eye surgery
vision care
|
|
gptkbp:spinOff
|
gptkb:Novartis
|
|
gptkbp:stockExchange
|
gptkb:New_York_Stock_Exchange
gptkb:SIX_Swiss_Exchange
|
|
gptkbp:stockSymbol
|
gptkb:ALC
|
|
gptkbp:subsidiary
|
gptkb:Novartis_(2010–2019)
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.alcon.com/
|
|
gptkbp:bfsParent
|
gptkb:Dallas–Fort_Worth
|
|
gptkbp:bfsLayer
|
5
|